featured
Clinical Activity of Regorafenib in Metastatic Colorectal Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Analysis of Circulating DNA and Protein Biomarkers to Predict the Clinical Activity of Regorafenib and Assess Prognosis in Patients With Metastatic Colorectal Cancer: A Retrospective, Exploratory Analysis of the CORRECT Trial
Lancet Oncol 2015 Jul 13;[EPub Ahead of Print], J Tabernero, HJ Lenz, S Siena, A Sobrero, A Falcone, M Ychou, Y Humblet, O Bouché, L Mineur, C Barone, A Adenis, T Yoshino, RM Goldberg, DJ Sargent, A Wagner, D Laurent, M Teufel, M Jeffers, A Grothey, E Van CutsemFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.